HR 7827 · 118th Congress · Health

To amend the Federal Food, Drug, and Cosmetic Act to encourage the development of vaccines to prevent, treat, or mitigate opioid, cocaine, methamphetamine, or alcohol use disorder, to establish an x-prize for the development of such a vaccine, and for other purposes.

Introduced 2024-03-26· Sponsored by Rep. Schweikert, David [R-AZ-1]· House

Bill Progress

Introduced
2
Committee
3
House Vote
4
Senate
5
Enacted
Latest: Referred to the Subcommittee on Health.(2024-03-29)

Plain Language Summary

[AI summary unavailable — showing source text] [Congressional Bills 118th Congress] [From the U.S. Government Publishing Office] [H.R. 7827 Introduced in House (IH)] <DOC> 118th CONGRESS 2d Session H. R. 7827 To amend the Federal Food, Drug, and Cosmetic Act to encourage the development of vaccines to prevent, treat, or mitigate opioid, cocaine, methamphetamine, or alcohol use disorder, to establish an x-prize for the development of such a vaccine, and for other purposes. _______________________________________________________________________ IN THE HOUSE OF REPRESENTATIVES March 26, 2024 Mr. Schweikert introduced the following bill; which was referred to the Committee on Energy and Commerce _______________________________________________________________________ A BILL To amend the Federal Food, Drug, and Cosmetic Act to encourage the development of vaccines to prevent, treat, or mitigate opioid, cocaine, methamphetamine, or alcohol use disorder, to establish an x-prize for the development of such a vaccine, and for other purposes. Be it enacted by the Senate and House of Representatives of the United States of America in Congress assembled, SECTION 1. ENCOURAGING DEVELOPMENT OF VACCINES FOR OPIOID, COCAINE, METHAMPHETAMI…

Summarized by Claude AI · Non-partisan · For informational purposes only